Anil Kapoor
Sunoco (United States)(US)People’s University(IN)St. Joseph’s Healthcare Hamilton(CA)Edward Via College of Osteopathic Medicine(US)McMaster University(CA)
Publications by Year
Research Areas
Renal cell carcinoma treatment, Renal and related cancers, Bladder and Urothelial Cancer Treatments, Prostate Cancer Treatment and Research, Cancer Genomics and Diagnostics
Most-Cited Works
- → Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma(2007)3,641 cited
- → Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma(2021)1,691 cited
- → Recurrent Uncomplicated Urinary Tract Infections in Women: AUA/CUA/SUFU Guideline(2019)449 cited
- → Cryoablation vs radiofrequency ablation for the treatment of renal cell carcinoma: a meta‐analysis of case series studies(2012)219 cited
- → A phase 3, randomized, 3-arm study of temsirolimus (TEMSR) or interferon-alpha (IFN) or the combination of TEMSR + IFN in the treatment of first-line, poor-risk patients with advanced renal cell carcinoma (adv RCC)(2006)210 cited
- → Guidelines for the diagnosis and management of recurrent urinary tract infection in women(2011)201 cited